Research Excellence Recognised
0th December
Professor Philip Hogg, from UNSW's Centre for Thrombosis and Vascular Research, has won the inaugural GlaxoSmithKline Australia Award for Research Excellence for his pioneering research on protein function.
The award recognises Professor Hogg's discovery of a new way that proteins work, which has pointed the way to innovative cancer, HIV/AIDS and thrombosis treatments. This discovery led Professor Hogg to design a synthetic compound that inhibits tumour blood vessel formation and tumour growth. The compound, known as GSAO, will be used in clinical trials next year.
As part of the Award, Professor Hogg receives an honorarium of $30,000. Earlier this year he received the 2001 Commonwealth Minister's Award for Excellence in Health and Medical Research.
The award recognises Professor Hogg's discovery of a new way that proteins work, which has pointed the way to innovative cancer, HIV/AIDS and thrombosis treatments. This discovery led Professor Hogg to design a synthetic compound that inhibits tumour blood vessel formation and tumour growth. The compound, known as GSAO, will be used in clinical trials next year.
As part of the Award, Professor Hogg receives an honorarium of $30,000. Earlier this year he received the 2001 Commonwealth Minister's Award for Excellence in Health and Medical Research.
Share on Facebook Add to Del.icio.us Digg this story |